Stem cell therapy for arthritis and joint pain: what the research shows
What the research actually shows about mesenchymal stem cell therapy for knee and joint arthritis, and the questions to ask before travelling for it.
Short answer
Mesenchymal stem cell (MSC) therapy for knee and joint arthritis is one of the more extensively studied applications of cellular therapy. Multiple systematic reviews and meta-analyses of clinical trials report meaningful improvements in pain and physical function after intra-articular MSC injection — but researchers are also clear that some of that improvement may come from placebo and other contextual effects, and that long-term safety and effectiveness data from large trials is still limited. It is not a guaranteed cure, and it is not right for every case — a licensed physician evaluates that.
What the research actually shows
- Pain and function. Reviews of randomized controlled trials report significant improvements in pain scores and standard function measures (such as WOMAC) after MSC injection into the knee, in some cases sustained through 12-month follow-up.
- How it’s thought to work. MSCs are studied for their ability to modulate local inflammation, support the joint’s microenvironment, and encourage tissue repair processes — not for regrowing new cartilage from scratch.
- An honest caveat. A 2025 meta-analysis specifically looking at contextual effects — the improvement patients experience from expectation, attention, and the injection procedure itself, independent of the cells — found that a substantial share of the reported benefit may come from these factors rather than the MSCs alone. This doesn’t mean MSC therapy doesn’t work; it means the size of the specific cellular effect is still being refined by ongoing research.
- Safety profile. Reported adverse events are generally mild — pain, swelling, or stiffness at the injection site (see our guide on why pain can flare before it improves). Reviewers consistently note that long-term data from larger trials is still needed.
Is it right for your case?
Arthritis and joint pain vary enormously by cause, severity, and joint involved. A physician reviews your imaging and history during your evaluation to explain whether a cellular therapy protocol is a reasonable option for your specific case, what to realistically expect, and what the alternatives are.
Not sure if this applies to you? Request a free evaluation →
Questions to ask before you travel
- What does the imaging and clinical exam actually show about my joint?
- Is my case a reasonable candidate for cellular therapy, or would another treatment be more appropriate?
- What outcome is realistic for someone with my specific diagnosis?
- Who performs the injection, and is the clinic government-licensed (COFEPRIS)?
Common questions
Does stem cell therapy regrow cartilage?
Current evidence points to MSCs modulating inflammation and supporting the joint environment more than regenerating new cartilage tissue outright. Ask your physician what mechanism is expected to help your specific case.
How much of the improvement is placebo?
Research is actively studying this. A 2025 meta-analysis found that contextual effects (expectation, attention, the injection process) account for a meaningful share of reported improvement — which is one reason realistic expectations, set by a licensed physician, matter more than marketing claims.
Is this approved by the FDA?
No — like other cellular therapies, MSC treatment for arthritis is not approved by the U.S. FDA or Health Canada for specific conditions and is considered investigational. See our guide on what “investigational” means and how Mexico regulates this.
How does this compare to exosome therapy for joints?
Both are studied for joint-related concerns, but they’re different biological approaches. See our stem cells vs. exosomes comparison for the distinction.
Further reading
- Mesenchymal stem cells in knee osteoarthritis treatment: A systematic review and meta-analysis — peer-reviewed, National Institutes of Health (NIH)
- Contextual effects of mesenchymal stem cell injections for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials — peer-reviewed, National Institutes of Health (NIH)
How Kern Stem Care helps
We connect you with government-licensed (COFEPRIS) physicians who review your specific case, explain realistic outcomes, and coordinate every part of the trip — so you get a straight answer before you travel, not a sales pitch. Request a free evaluation to start.